Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
CNS Pharmaceuticals, Inc. (CNSP) had Cash Flow from Investing Activities of $-0.01M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-4.94M |
|
-- |
|
-- |
|
$4.98M |
|
$-4.98M |
|
$0.04M |
|
$-4.94M |
|
$-4.94M |
|
$-4.94M |
|
$-4.94M |
|
$-4.94M |
|
$-4.94M |
|
$-4.98M |
|
$-4.97M |
|
0.68M |
|
0.68M |
|
$-7.30 |
|
$-7.30 |
|
| Balance Sheet Financials | |
$4.08M |
|
$0.02M |
|
$0.57M |
|
$4.65M |
|
$4.58M |
|
-- |
|
-- |
|
$4.58M |
|
$0.07M |
|
$0.07M |
|
$0.07M |
|
0.81M |
|
| Cash Flow Statement Financials | |
$-4.65M |
|
|
Cash Flow from Investing Activities |
$-0.01M |
$0.40M |
|
$7.20M |
|
$2.95M |
|
$-4.25M |
|
$0.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.89 |
|
-- |
|
-- |
|
-- |
|
3.29 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.65M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6982.18% |
|
-6982.60% |
|
-106.10% |
|
-6982.60% |
|
$0.09 |
|
$-6.89 |
|
$-6.88 |
|